Now Available: Our 2023 State of Patient Empowerment Report Learn more >>
Now Available: Our 2023 State of Patient Empowerment Report Learn more >>
Suzanne Garner
Cancer Survivor, Outcomes4Me User
We’re the only non-metastatic breast cancer app that integrates with the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), from the not-for-profit alliance of 33 leading cancer centers. The NCCN Guidelines® include comprehensive guidance related to all FDA-approved treatment options.
We gather non-metastatic breast cancer treatment recommendations typically meant for oncologists and use Artificial Intelligence (AI) to translate that information so you can understand it, putting you in control. With this knowledge, you can feel empowered to make the best medical decisions with your care team.
With our free non-metastatic breast cancer app, you’ll get:
Gain direct access to personalized treatment options so you can have more informed conversations with your care team.
Rely on us to help your patients get access to the best non-metastatic breast cancer care and resources, and save time in your day. We’re here to help and won’t ever get in the way.
Accelerate patient access to your treatments and expand the reach of your non-metastatic breast cancer research and clinical trials.
Get all the information you need to take a more active role in treating your non-metastatic breast cancer.
Non-metastatic breast cancer refers to breast cancer that has not spread beyond the primary site of origin, typically the breast and the nearby lymph nodes. In other words, the cancer cells have not invaded distant organs or tissues. The term “non-metastatic” is often used interchangeably with “localized” or “early-stage” breast cancer.
The staging system is commonly used to categorize the extent of cancer spread. Stages 0, 1, 2, and some cases of Stage 3 breast cancer are considered non-metastatic or localized, meaning they are confined to the breast or have only spread to nearby lymph nodes.
The 5-year relative survival rate for women in the United States with non-metastatic invasive breast cancer is ~91%. The 10-year relative survival rate for women with non-metastatic invasive breast cancer is ~85%. It is important to note that many factors influence overall survival rates including the tumor risk group, treatment and lifestyle.
Source: NCCN
https://www.nccn.org/patients/guidelines/content/PDF/breast-invasive-patient.pdf
Source: Cancer.net.
https://www.cancer.net/cancer-types/breast-cancer/statistics#:~:text=The%205%2Dyear%20relative%20survival%20rate%20for%20women%20in%20the,invasive%20breast%20cancer%20is%2085%25.
By clicking the “Subscribe Now” button you’re agreeing to our Terms of Service and Privacy Policy.
